| Trial ID: | L6988 |
| Source ID: | NCT00145093
|
| Associated Drug: |
Baker's Yeast (Bio Chromium)
|
| Title: |
Effects of Chromium Supplementation on Parameters of the Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Baker's yeast (Bio Chromium)
|
| Outcome Measures: |
Primary: To determine the effect of Baker's yeast treatment on glycemicic control and insulin resistance when given in combination with oral blood glucose lowering therapy to patients with type 2 diabetes mellitus | Secondary: To determine the effect of Baker's yeast treatment on serum lipids, blood pressure, body fat percentage and BMI when given in combination with oral blood glucose lowering therapy to patients with type 2 diabetes mellitus
|
| Sponsor/Collaborators: |
Sponsor: Medical Research Foundation, The Netherlands | Collaborators: Pharma Nord
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-08
|
| Completion Date: |
2005-02
|
| Results First Posted: |
|
| Last Update Posted: |
2005-11-22
|
| Locations: |
General Practice, Heerde, Netherlands
|
| URL: |
https://clinicaltrials.gov/show/NCT00145093
|
